BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15490352)

  • 21. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PSYCHOPHARMACOLOGY OF ANTIPARKINSONIAN DRUGS].
    Arushanyan EB; Naumov SS
    Eksp Klin Farmakol; 2017; 80(1):32-38. PubMed ID: 29874001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 24. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Psychological and cognitive problems in Parkinson disease--therapeutic possibilities].
    Baronti F
    Praxis (Bern 1994); 2002 Mar; 91(10):411-7. PubMed ID: 11933648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropsychiatric and cognitive symptoms in Parkinson disease].
    Aarsland D; Pedersen KF; Ehrt U; Bronnick K; Gjerstad MD; Larsen JP
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2072-6. PubMed ID: 18846124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dopaminergic stimulation in the non-motor symptoms of Parkinson's disease].
    Martínez-Pueyo A; Berrocal-Izquierdo N; Castrillo-Sanz A; Rodríguez-Vico JS
    Rev Neurol; 2010 Feb; 50 Suppl 2():S85-94. PubMed ID: 20205148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects].
    Sobrido MJ; Dias-Silva JJ; Quintáns B
    Rev Neurol; 2009 Jan; 48 Suppl 1():S43-8. PubMed ID: 19222015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.
    Verdoux H; Pambrun E
    Acta Psychiatr Scand; 2014 Dec; 130(6):487-97. PubMed ID: 25302631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmotor symptoms in Parkinson's disease.
    Stacy M
    Int J Neurosci; 2011; 121 Suppl 2():9-17. PubMed ID: 22035025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease].
    Chacón J
    Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosis, apathy, depression and anxiety in Parkinson's disease.
    Gallagher DA; Schrag A
    Neurobiol Dis; 2012 Jun; 46(3):581-9. PubMed ID: 22245219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of behavioural disturbances in Parkinson's disease.
    Valldeoriola F; Nobbe FA; Tolosa E
    J Neural Transm Suppl; 1997; 51():175-204. PubMed ID: 9470138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.